Phathom Pharmaceuticals Inc (PHAT)
EBITDA Growth
95.93%
Quarterly · Period ending:
PHAT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported95.93%period ending
Latest reported95.93%period ending
PHAT Quarterly EBITDA YoY % (-23019.58% → 95.93%)
Year-over-year change
High-resolution chart · PNG
PHAT ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 95.9308% | |
| 80.9881% | |
| 91.7345% | |
| 79.5088% | |
| 20.909% | |
| -16.1876% | |
| 16.1116% | |
| -102.6412% | |
| -135.3252% | |
| -130.1149% | |
| -46.5556% | |
| 20.7114% | |
| 30.7667% | |
| 24.689% | |
| -37.5532% | |
| -18.809% | |
| -28.2639% | |
| -12.9522% | |
| 37.1028% | |
| -7.0759% | |
| -77.9425% | |
| -72.8386% | |
| 46.0268% | |
| 50.4991% | |
| 76.0484% | |
| -138,121.4286% | |
| -20,142.38% | |
| -23,019.5804% |